| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-14 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-12 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-10 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-10 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-10 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
9e-10 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-09 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-09 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-08 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-08 |